Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Established in 1907, the Association of Physicians of Great Britain and Ireland (AoPGBI) has traditionally only invited the highest-profile doctors and researchers to its annual meeting. Now, they have made the landmark decision to open their (virtual) doors to the wider medical community, primarily to clinicians, early career researchers, discovery scientists and industry affiliates.

Association of Physicians of Great Britain & Ireland logo

The meeting (taking place on Monday 15 & Tuesday 16 March) is a rare opportunity to hear some of the UK and Ireland’s most esteemed medics and scientists share their first-hand views on selected medical issues of the day.

View the programme here

Speakers and their topics include:

Dr Rino Rappuoli, Chief Scientist of the vaccines division, GSK, on global preparedness and vaccines of the future.

Professor Ellie Barnes (Nuffield Departent of Medicine), on vaccines and elimination of viral hepatitis. Both speakers feature in a new series of podcasts by broadcaster, Vivienne Parry, and available to download here.

Professor Martin Landray (Nuffield Department of Population Health) on how using routine healthcare data will become the new normal in clinical trial work.

Professor Eva Morris (Nuffield Department of Population Health) on the establishment of the UK Colorectal Cancer Intelligence Hub.

Professor Dennis Lo from the Chinese University of Hong Kong on new insights into use of non-invasive DNA testing in blood for disease diagnosis. 

Professor Paul Workman, president of the Institute of Cancer Research, London on drugging the cancer genome, cancer evolution and drug resistance.

Professor Sir Peter Ratcliffe, Nobel Prize winner 2019, and Director for the Target Discovery Institute, University of Oxford on cell detection and response to low oxygen could inform new treatments .

AoP Annual Meeting presentations can be viewed for one month from the 16th March via aopgbi.org- please register for access.

AoPGBI Podcasts

AoPcasts is a fascinating series of podcasts bringing cutting edge medical research to new audiences.  Produced by the Association of Physicians and hosted by science broadcaster Vivienne Parry, the series will explore some of the major themes debated at the annual AoP meeting. 

The first AoPcast brings together Rino Rappuoli, Chief Scientist of the vaccines division of GSK and Fellow both of the Royal Society and the US National Academy of Sciences, and Professor Ellie Barnes (Nuffield Departent of Medicine), globally celebrated for her work on hepatitis vaccines.

AoPcasts are available for download on the Association of Physicians website (aopgbi.org) and from your favourite podcast site. Listen to an AoPcasts podcast

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology

The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.